These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 29030532)

  • 1. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality.
    Gikanga B; Chen Y; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on Mixing-Induced Protein Particle Formation: The Puzzle of Bottom-Mounted Mixers.
    Gikanga B; Maa YF
    J Pharm Sci; 2020 Aug; 109(8):2363-2374. PubMed ID: 32240688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution.
    Nayak A; Colandene J; Bradford V; Perkins M
    J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
    Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Grinding-Induced Subvisible Particles and Free Radicals in a Freeze-Dried Monoclonal Antibody Formulation.
    Jing ZY; Huo GL; Sun MF; Shen BB; Fang WJ
    Pharm Res; 2022 Feb; 39(2):399-410. PubMed ID: 35083639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.
    Li L; Kirkitadze M; Bhandal K; Roque C; Yang E; Carpick B; Rahman N
    Curr Pharm Biotechnol; 2017 Nov; 18(8):638-647. PubMed ID: 28914197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of syringe surfaces on protein formulations.
    Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
    J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Impact of Combined Hydrodynamic Shear and Interfacial Dilatational Stress, on Interface-Mediated Particle Formation for Monoclonal Antibody Formulations.
    Griffin VP; Pace S; Ogunyankin MO; Holstein M; Hung J; Dhar P
    J Pharm Sci; 2024 Aug; 113(8):2081-2092. PubMed ID: 38615816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shipping-Induced Aggregation in Therapeutic Antibodies: Utilization of a Scale-Down Model to Assess Degradation in Monoclonal Antibodies.
    Fleischman ML; Chung J; Paul EP; Lewus RA
    J Pharm Sci; 2017 Apr; 106(4):994-1000. PubMed ID: 27964939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight into Polysorbate 20 Degradation Pathway.
    Saggu M; Liu J; Patel A
    Pharm Res; 2015 Sep; 32(9):2877-88. PubMed ID: 25773722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of lyophilized sucrose formulations of an IgG1: subvisible particle formation.
    Davis JM; Zhang N; Payne RW; Murphy BM; Abdul-Fattah AM; Matsuura JE; Herman AC; Manning MC
    Pharm Dev Technol; 2013; 18(4):883-96. PubMed ID: 22813478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Combined Impact of Temperature and Application of Interfacial Dilatational Stresses on Surface-mediated Protein Particle Formation in Monoclonal Antibody Formulations.
    Griffin VP; Merritt K; Vaclaw C; Whitaker N; Volkin DB; Ogunyankin MO; Pace S; Dhar P
    J Pharm Sci; 2022 Mar; 111(3):680-689. PubMed ID: 34742729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filling of High-Concentration Monoclonal Antibody Formulations: Investigating Underlying Mechanisms That Affect Precision of Low-Volume Fill by Peristaltic Pump.
    Shieu W; Lamar D; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2016; 70(2):143-56. PubMed ID: 26797970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of protein sub-visible particles during powder grinding of a monoclonal antibody.
    Qian C; Wang G; Wang X; Barnard J; Gao JQ; Bao W; Wang H; Li F; Ingle RG; Fang WJ
    Eur J Pharm Biopharm; 2020 Apr; 149():1-11. PubMed ID: 32006605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of particle shedding from silicone tubing on antibody stability.
    Saller V; Hediger C; Matilainen J; Grauschopf U; Bechtold-Peters K; Mahler HC; Friess W
    J Pharm Pharmacol; 2018 May; 70(5):675-685. PubMed ID: 27367430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
    Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
    Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low volume aseptic filling: Impact of pump systems on shear stress.
    Dreckmann T; Boeuf J; Ludwig IS; Lümkemann J; Huwyler J
    Eur J Pharm Biopharm; 2020 Feb; 147():10-18. PubMed ID: 31837391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.